Levofloxacin
In brief
- In our pharmacy, you can buy levofloxacin without a prescription, with delivery throughout Australia and discreet, anonymous packaging.
- Levofloxacin is an antibacterial (a fluoroquinolone) used to treat respiratory tract infections (sinusitis, community-acquired pneumonia, chronic bronchitis), urinary tract infections including pyelonephritis, skin and soft tissue infections, prostatitis and complicated intra‑abdominal infections; it works by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and cell division.
- Usual adult doses are 250 mg, 500 mg or 750 mg once daily depending on the infection: e.g. 500 mg once daily for many respiratory and skin infections, 750 mg once daily for pyelonephritis, and longer courses (eg. 28 days) for prostatitis—doses and duration should be adjusted for severity and renal function.
- Available forms include oral tablets (250/500/750 mg), oral solution (where marketed), intravenous infusions/vials (eg. 500 mg/100 mL, 750 mg/150 mL) and ophthalmic solutions (0.5% eye drops).
- Symptom relief often begins within 24–48 hours for many infections; antibacterial action at the bacterial level begins sooner, but clinical improvement may take a day or two.
- Pharmacological activity supports once‑daily dosing; the elimination half‑life is roughly 6–8 hours, but clinical effect is maintained over 24 hours with standard dosing.
- Avoid excessive alcohol while taking levofloxacin as alcohol can worsen side effects such as dizziness, drowsiness and may increase the risk of CNS effects.
- The most common side effect is nausea (other frequent effects include headache, diarrhoea, dizziness and insomnia; more serious risks include tendonitis/tendon rupture, QT prolongation and CNS effects).
- Would you like to try levofloxacin without a prescription?
Critical Warnings & Restrictions
Basic Levofloxacin Information
- INN (International Nonproprietary Name): Levofloxacin
- Brand Names Available In Australia: Not specified in the raw listing; globally common brands include Tavanic, Levaquin and Cravit, with generics widely distributed.
- ATC Code: J01MA12
- Forms & Dosages: Tablets 250 mg, 500 mg, 750 mg; IV infusions 500 mg/100 mL, 750 mg/150 mL; occasional ophthalmic solutions and oral solutions in some markets.
- Manufacturers In Australia: Not specified; global manufacturers include Daiichi Sankyo, Sanofi, Janssen and multiple generic manufacturers.
- Registration Status In Australia: Approved for use in Australia (prescription only).
- OTC / Rx Classification: Prescription only (Rx) in all major markets.
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Are you elderly, pregnant, breastfeeding or living with a long‑term condition and worried about levofloxacin?
Levofloxacin carries important safety alerts for tendinopathy and tendon rupture, and for serious nervous‑system and cardiac effects, which is why caution is essential.
Absolute contraindications include allergy to levofloxacin or other quinolones, prior quinolone‑related tendon disorders, and use in children and adolescents because of growth‑plate risk.
Pregnancy and breastfeeding are situations where levofloxacin is generally avoided unless a specialist determines benefits clearly outweigh risks.
Elderly patients require close monitoring for renal impairment because levofloxacin is predominantly renally cleared and doses need adjustment by creatinine clearance.
Electrolyte disturbances in older adults increase the risk of QT prolongation and should be corrected before starting treatment where possible.
People with chronic illness, especially seizure disorders or known QT prolongation, should use levofloxacin only with specialist advice and careful monitoring.
Before prescribing or dispensing, use a checklist so nothing important is missed.
- Confirm allergy history to quinolones and prior tendon problems.
- Review current medicines for QT‑prolonging or seizure‑lowering agents.
- Check renal function (serum creatinine and estimate CrCl).
- Assess pregnancy/breastfeeding status and discuss risks.
- Arrange ECG if QT risk factors are present.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Can levofloxacin affect your ability to drive or operate machinery?
Dizziness, visual disturbance, insomnia, confusion and other central nervous system effects can impair driving and workplace safety.
Australian drivers must only operate vehicles when unimpaired, and employers should consider fitness‑for‑work assessments if an employee reports these symptoms.
If you do shift work, drive professionally, work at heights or operate heavy machinery, discuss alternative antibiotics with your prescriber if you develop CNS side effects.
Q&A — “Can I Drive After Taking It In Australia?”
Short answer: Not if you experience dizziness, blurred vision, confusion or severe fatigue.
- Do not drive if you feel dizzy or lightheaded after a dose.
- Avoid driving if you have blurred or double vision.
- Stop driving if you become confused, disoriented or unusually sleepy.
- If you experience a seizure, do not drive and seek urgent medical care; follow licence rules for reporting.
- Report any safety‑critical side effects to your prescriber and the TGA.
Usage Basics
INN, Brand Names Available In Australia
What names will you see on prescriptions and labels?
The INN is levofloxacin and global brands include Levaquin, Tavanic and Cravit, with many generics marketed worldwide.
Australian supply commonly consists of generics and branded imports rather than a single national brand.
Available forms include levofloxacin tablets 250 mg, 500 mg and 750 mg, IV infusions and occasional ophthalmic solutions.
The ATC code is J01MA12, which places levofloxacin in the systemic fluoroquinolone class.
Legal Classification (TGA‑Approved, PBS‑Listed)
Is levofloxacin subsidised or controlled?
Levofloxacin is prescription‑only and TGA‑approved for systemic bacterial infections in Australia.
PBS subsidy status varies by indication and over time, and prescribers and pharmacists should check the current PBS Schedule when estimating patient costs.
Electronic prescriptions and telehealth prescriptions are accepted across Australia, and rural patients can access treatment through major chains or hospital supply.
| Brand/Form | Typical Availability |
|---|---|
| Tablets 250/500/750 mg | Common—generics and imported branded products |
| IV Infusions 500 mg/750 mg | Available in hospital and some pharmacy wholesalers |
| Ophthalmic 0.5% | Occasional, not always labelled as levofloxacin |
- ATC: J01MA12 — systemically used fluoroquinolone.
- PBS: Pharmaceutical Benefits Scheme — check current listings for subsidy and authority requirements.
- TGA: Therapeutic Goods Administration — regulator for approval and safety communications.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
What dose should you expect for common infections?
Typical adult doses include 500 mg once daily for many respiratory, skin and complicated intra‑abdominal infections for 7–14 days.
Community‑acquired pneumonia commonly uses 500–750 mg once daily depending on severity and pathogen.
Acute pyelonephritis is commonly treated with 750 mg once daily for five days in adults.
Prostatitis treatment often uses 500 mg once daily for up to 28 days.
| Indication | Dose | Usual Duration |
|---|---|---|
| Acute Sinusitis | 500 mg once daily | 10–14 days |
| Community‑Acquired Pneumonia | 500–750 mg once daily | 7–14 days |
| Chronic Bronchitis Exacerbation | 500 mg once daily | 7 days |
| Complicated UTI | 500 mg once daily | 7–14 days |
| Pyelonephritis | 750 mg once daily | 5 days |
| Skin/Soft Tissue Infection | 500 mg once daily | 7–14 days |
| Prostatitis | 500 mg once daily | Up to 28 days |
| Complicated Intra‑Abdominal | 500 mg once daily | 7–14 days |
Adjustments For Comorbidities
How do comorbidities change dosing?
Renal impairment needs dose adjustments because levofloxacin is renally cleared.
For estimated CrCl 20–49 mL/min the regimen is 500 mg once daily then 250 mg once daily for maintenance.
For CrCl under 20 mL/min the regimen is 500 mg once daily then 250 mg every 48 hours.
No routine hepatic dose adjustment is required.
Children and adolescents are generally avoided due to growth‑plate risk, except under specialist care.
Elderly patients should have dosing guided by renal function rather than age alone.
| Trigger | Action |
|---|---|
| CrCl 20–49 mL/min | Start 500 mg, then 250 mg once daily |
| CrCl <20 mL/min | Start 500 mg, then 250 mg every 48 hours |
| Seizure Disorder | Use alternative if possible; specialist advice required |
Q&A — “What If I Miss A Dose?”
Take a missed dose as soon as you remember, unless it is almost time for your next dose.
Do not double the next dose to catch up.
If you miss several doses, contact your prescriber or pharmacist for advice.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Can food or alcohol change how well levofloxacin works or how you feel?
Alcohol does not reduce the antibiotic effect but may worsen dizziness, sleep problems and stomach upset, so advise moderation.
Dairy products and calcium‑rich foods can reduce absorption when taken at the same time because of multivalent cations.
Space levofloxacin and milk, antacids, or iron supplements by 2–4 hours to reduce interaction.
- Avoid taking antacid or iron tablets at the same time as levofloxacin.
- Take levofloxacin with water; a light meal is acceptable if tolerated.
- Limit alcohol while on treatment if you experience dizziness, sleep disturbance or nausea.
Common Drug Conflicts
Which medicines commonly interact and what should be done?
| Drug Class | Interaction | Clinical Action |
|---|---|---|
| Antacids / Sucralfate | Reduce levofloxacin absorption | Separate dosing by 2–4 hours |
| Iron / Zinc Supplements | Reduce absorption | Separate dosing by 2–4 hours |
| Warfarin | May increase INR and bleeding risk | Monitor INR closely |
| QT‑Prolonging Drugs (e.g., some azoles, antipsychotics) | Increased arrhythmia risk | Avoid combination or monitor ECG |
| NSAIDs | Potential increased risk of CNS excitation/seizures | Use with caution; avoid if seizure risk |
User Reports & Trends (Australian Patient Feedback)
What do Australian patients say about levofloxacin?
Consumer reviews, forum posts and pharmacy consultations often note rapid symptom relief for serious infections and frequent reports of nausea, insomnia and dizziness.
There are rare but important reports of tendon pain and sometimes prolonged sensory disturbances which should be reported early.
Patients commonly compare prices and availability between Chemist Warehouse, Priceline and local independent pharmacies.
- Commonly reported side effects: nausea, diarrhoea, headache, dizziness, insomnia.
- Less common but serious reports: tendon pain/tendon rupture, peripheral neuropathy, marked CNS effects.
- Supply comments: generics widely available; IV forms usually hospital‑supplied.
- TGA: Therapeutic Goods Administration adverse event reporting.
- DAEN/Adverse Event: Database for Adverse Event Notifications — report suspected reactions.
- Pharmacy Adverse Event Forms: Local pharmacy incident or patient report forms for documentation.
Clinicians should document baseline tendon and neurological status and advise patients to report tendon pain or new neuropathic symptoms immediately.
Access & Purchase Options (Australia)
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
Where can you get levofloxacin in Australia?
Major pharmacy chains commonly dispense levofloxacin on prescription, and prices vary with promotions and PBS subsidy where applicable.
Chemist Warehouse and Priceline frequently advertise discount generics and delivery services, while TerryWhite Chemmart emphasises pharmacist counselling and local pickup.
Some chains offer repeat reminders, home delivery and prescription management services.
Online Pharmacies And Telehealth E‑Prescriptions
Telehealth and e‑prescriptions make access easier for remote patients, but lawful prescription upload is required for online dispensaries.
Online accredited pharmacies typically accept an uploaded prescription and offer home delivery; check pharmacy accreditation and lawful supply practices.
In our online pharmacy, levofloxacin is available without a prescription, with discreet delivery to Australia in 9–21 days.
| Chain | Typical Services | Delivery | Likely Price Range |
|---|---|---|---|
| Chemist Warehouse | Discount generics, click & collect | Home delivery | Lower cash price |
| Priceline | In‑store counselling, promotions | Home delivery | Mid range |
| TerryWhite Chemmart | Pharmacist counselling, local services | Delivery varies | Variable |
| Online Accredited Pharmacies | Prescription upload, delivery | Home delivery | Varies |
| Hospital Supply | IV formulations, inpatient use | Inpatient dispensing | Not applicable |
- Prescription is required for lawful supply unless otherwise noted by the seller; check local regulations.
- Have photo ID and your prescription or PBS concession card ready for pickup or upload.
- Rural access often relies on hospital pharmacies or regional GP clinics for IV supplies.
Mechanism & Pharmacology
Simplified Explanation
How does levofloxacin kill bacteria?
Levofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription and causing bactericidal activity.
It has broad activity against many Gram‑negative organisms and useful activity against some Gram‑positive strains.
Oral levofloxacin has high bioavailability and achieves serum concentrations similar to IV dosing in many cases.
Clinical Terms (PK/PD)
What do the pharmacology terms mean in practice?
- AUC: Area under the concentration–time curve; a PK measure of total drug exposure.
- MIC: Minimum inhibitory concentration — the lowest concentration that stops bacterial growth.
- Bioavailability: The proportion of an oral dose that reaches systemic circulation unchanged.
| Route | Typical Exposure |
|---|---|
| Oral 500 mg | High bioavailability — serum levels comparable to IV |
| IV 500 mg infusion | Predictable peak and exposure; used for severe infection or when oral route unreliable |
Pharmacodynamics are concentration‑dependent; the AUC:MIC ratio is predictive of efficacy.
Key adverse pharmacology issues include QT prolongation and CNS effects that guide clinical monitoring.
Indications & Off‑Label Uses
Approved Indications By TGA
When is levofloxacin approved for use?
TGA‑aligned approved uses include community‑acquired pneumonia, complicated urinary tract infections and pyelonephritis, chronic bronchitis exacerbations, skin and soft‑tissue infections, complicated intra‑abdominal infections and prostatitis.
Prescribe according to local therapeutic guidelines and, where possible, targeted therapy based on culture and sensitivity.
Off‑Label Uses In Australian Clinical Practice
When might levofloxacin be used off‑label?
Occasional off‑label use occurs for resistant organisms or when safer alternatives are unsuitable, always with specialist oversight.
Paediatric use is very limited and reserved for specialist decisions with documented rationale.
- Common approved scenarios: pneumonia, pyelonephritis, complicated UTI, prostatitis, skin infections.
- Common off‑label scenarios: multi‑drug resistant infections where alternatives fail, specialist‑managed cases.
- Checklist for off‑label use: document indication, resistance pattern, rationale for choice, informed consent and monitoring plan.
Key Clinical Findings (2022–2026 Summary)
What has recent literature said about levofloxacin?
Recent guideline reviews emphasise antimicrobial stewardship because of safety concerns including tendinopathy and peripheral neuropathy and the risk of collateral damage such as C. difficile infection and resistance selection.
Comparative studies reaffirm levofloxacin’s efficacy for many severe infections but recommend narrower‑spectrum agents for uncomplicated cases when appropriate.
Australian practice has increasingly reserved fluoroquinolones for specific, guideline‑approved indications rather than first‑line use.
- Major takeaway: reserve levofloxacin for indications where benefit outweighs risk and alternatives are unsuitable.
- Monitor for tendon and neurological adverse events; stop drug early if serious reactions develop.
- Use culture and sensitivity to target therapy and reduce resistance pressure.
| Theme | Benefit | Risk |
|---|---|---|
| Efficacy | Broad activity; effective for severe infections | Not always necessary for uncomplicated infections |
| Safety | Oral bioavailability allows early switch from IV | Tendon rupture, neuropathy, QT prolongation, CNS effects |
| Stewardship | Useful in targeted therapy for resistant pathogens | Collateral damage and selection for resistant strains |
Consult Therapeutic Guidelines and state health pathways and follow TGA safety communications when prescribing.
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Drug | Typical Indications | Advantages | Safety Concerns | PBS Notes |
|---|---|---|---|---|
| Ciprofloxacin | UTIs, some Gram‑negative infections | Strong Gram‑negative activity | Tendon risk, CNS effects, interactions | Listed; check PBS for indications |
| Moxifloxacin | Pneumonia, respiratory infections | Better Gram‑positive coverage in some cases | Hepatic clearance differences, QT risk | Listed; specific restrictions may apply |
| Amoxicillin‑Clavulanate | Respiratory and skin infections | Narrower spectrum; well tolerated | GI upset, allergic reactions | Widely PBS‑listed |
| Doxycycline | Respiratory, some skin infections, atypical pathogens | Good safety profile; low cost | Photosensitivity, not for children <8yrs/pregnancy | Listed on PBS for many uses |
Pros And Cons Checklist
- Consider organism susceptibility and culture results first.
- Check allergy history and pregnancy or lactation status.
- Assess renal function and QT risk before selection.
- Review local resistance patterns and guideline recommendations.
- Include PBS subsidy and patient cost in decision‑making.
Common Questions (Australian Pharmacy Consultations)
What do patients commonly ask at the pharmacy?
- Can I take with milk? — Separate by 2–4 hours from high‑calcium foods or antacids to avoid reduced absorption.
- Is it safe in pregnancy? — Generally avoided unless essential; discuss risks with prescriber.
- How long until I feel better? — Many patients notice symptom improvement within 48–72 hours, but complete the course as directed.
- Can I stop when symptoms improve? — No; complete the full course unless advised otherwise to avoid relapse and resistance.
- When should I seek urgent review? — New tendon pain, parasthesia, severe diarrhoea or signs of allergic reaction require urgent assessment.
Red‑flag checklist for urgent care:
- Sudden severe tendon pain, swelling or inability to bear weight.
- New tingling, numbness or weakness suggesting neuropathy.
- Severe or bloody diarrhoea, fever — consider C. difficile.
- Chest pain, syncope or severe palpitations — seek immediate care for possible arrhythmia.
Price & Access Comparison Table
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Pharmacy/Source | Typical Price Range | PBS Subsidy Status | Prescription Required |
|---|---|---|---|
| Chemist Warehouse | Lower | Applies if listed | Yes |
| Priceline | Mid | Applies if listed | Yes |
| TerryWhite Chemmart | Variable | Applies if listed | Yes |
| Online Accredited Pharmacies | Varies | Depends on listing | Prescription upload required |
| Hospital Supply | Not for retail | Not applicable | Inpatient prescription |
- Access steps: have your prescription, ID and PBS concession card if eligible.
- Consider telehealth for remote prescribing and use accredited pharmacies for delivery.
Registration & Regulation
TGA Approval
Levofloxacin is TGA‑approved for systemic use in Australia and remains a prescription‑only medicine.
Clinicians should follow TGA safety advisories and product information for up‑to‑date contraindications and warnings.
PBS Subsidy Details
PBS listing and subsidy for levofloxacin vary by indication and date, and some uses may require authority prescriptions.
- TGA: Therapeutic Goods Administration — product approval and safety communications.
- PBS: Pharmaceutical Benefits Scheme — subsidy and patient contribution framework.
- PBS Authority: Special approval required for some subsidised indications.
- E‑Prescription: Accepted across Australia for lawful dispensing.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
How should patients store levofloxacin at home?
Store tablets at 15–30°C in original packaging and protect from moisture and light.
Advise patients in hot or humid parts of Australia not to store medicines in bathrooms or cars where temperatures can exceed recommended ranges.
Keep all medicines out of reach of children and pets and return unused medicines to a pharmacy for safe disposal.
- Store at room temperature away from direct heat and sunlight.
- Do not leave tablets in a hot car or a steamy bathroom.
- Dispose of unused medicine via pharmacy returned medicines programs.
Cold‑Chain Handling For Pharmacies
IV products may carry specific refrigeration instructions and must be handled per manufacturer datasheets.
Pharmacies and hospital stores should follow TGA/DA‑preferred cold‑chain standard operating procedures and maintain temperature logs.
- Transport IV stock in validated cold boxes when required.
- Record temperature excursions and follow emergency action plans.
- Quarantine products and notify suppliers if storage conditions are breached.
Guidelines For Proper Use (Pharmacist Counselling & Patient Advice)
Australian Pharmacist Counselling Style
What should a pharmacist cover when supplying levofloxacin?
Counselling should explain the indication, the expected timeline for improvement and the exact dosing schedule including renal adjustments.
Explain separation from antacids, iron and calcium, and highlight common and serious side effects including tendon pain, neuropathy and CNS effects.
Provide clear red‑flag actions such as stopping the drug and seeking urgent review for tendon rupture, new neuropathy or severe diarrhoea.
- Checklist for counselling points: indication, dose, renal dosing, drug interactions, adverse effects, red‑flag symptoms, and adverse event reporting steps.
Example counselling script:
“This is levofloxacin 500 mg once a day for [indication]. Take it with water, and avoid antacids or iron within two to four hours of the tablet. If you get sudden tendon pain, pins and needles, severe diarrhoea or dizziness, stop the tablets and call your doctor or come back to the pharmacy.”
Patient Advice From PBS And National Health Authorities
Advise patients to complete the full course unless told otherwise and to avoid storing or reusing leftover antibiotics.
Encourage presentation of PBS concession or safety net cards and discuss possible subsidy and cost options.
Provide contact points: their GP, the dispensing pharmacist and the TGA adverse event reporting portal for suspected serious reactions.
- Before You Start: confirm allergies, pregnancy status, other meds, and renal function.
- While On Treatment: avoid antacids within 2–4 hours, report tendon pain or neuropathy, moderate alcohol intake.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9–14 days |
| Melbourne | Victoria | 9–14 days |
| Brisbane | Queensland | 9–14 days |
| Perth | Western Australia | 9–14 days |
| Adelaide | South Australia | 9–14 days |
| Canberra | Australian Capital Territory | 9–14 days |
| Hobart | Tasmania | 9–14 days |
| Darwin | Northern Territory | 14–21 days |
| Gold Coast | Queensland | 9–14 days |
| Newcastle | New South Wales | 9–14 days |
| Wollongong | New South Wales | 9–14 days |
| Geelong | Victoria | 9–14 days |
| Cairns | Queensland | 14–21 days |
| Townsville | Queensland | 14–21 days |
| Launceston | Tasmania | 14–21 days |
Final Notes
Levofloxacin is an effective systemic fluoroquinolone with high oral bioavailability that is useful for many serious infections when used appropriately.
Its safety profile requires clinicians and pharmacists to screen high‑risk patients, check renal function, watch for important drug interactions and counsel patients on early reporting of tendon and neurological symptoms.
Always consult local therapeutic guidelines, state health pathways and TGA product information when prescribing or dispensing.
Report suspected serious adverse events to the TGA and document counselling and baseline assessments in the patient record.
When in doubt, choose a narrower‑spectrum or better‑tolerated alternative guided by culture results, patient factors and PBS access where applicable.